In 2024, the global oral proteins and peptides market reached a valuation of USD 1.8 Billion, with forecasts by IMARC Group predicting a surge to USD 3.4 Billion by 2033 at a CAGR of 7.13% (2025-2033). Dominating the market with a 97.8% share in 2024, North America drives growth through cutting-edge drug delivery advancements and a strong preference for non-invasive therapies. The ris... https://www.imarcgroup.com/oral-proteins-peptides-market